Top Buy
Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
---|---|---|---|---|---|---|---|
CONMED Corp. | 12 | 1 | 4 | 0 | €66.50 | €106.18 | 59.668% |
Align Technology | 15 | 2 | 4 | 0 | €253.60 | €345.95 | 36.416% |
Cytokinetics Inc. | 27 | 1 | 4 | 0 | €56.00 | €85.64 | 52.935% |
Heron Therapeutics Inc. | 11 | 1 | 4 | 0 | €2.85 | €4.59 | 61.018% |
Humana Inc. | 23 | 0 | 3 | 0 | €327.00 | €439.88 | 34.519% |
Pacira Pharmaceuticals | 18 | 0 | 3 | 0 | €27.40 | €47.53 | 73.460% |
Medpace Holdings Inc | 9 | 0 | 3 | 0 | €369.80 | €421.61 | 14.009% |
Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €38.80 | €84.74 | 118.412% |
Krystal Biotech | 17 | 0 | 3 | 0 | €149.20 | €179.60 | 20.372% |
Incyte Corp. | 12 | 2 | 3 | 0 | €52.14 | €78.42 | 50.407% |
United Therapeutics | 18 | 0 | 3 | 0 | €251.50 | €288.66 | 14.776% |
Twist Bioscience Corp | 7 | 0 | 3 | 0 | €43.89 | €41.65 | -5.109% |
Halozyme Therapeutics Inc. | 14 | 0 | 3 | 0 | €42.35 | €50.33 | 18.849% |
Atossa Genetics Inc | 7 | 1 | 3 | 0 | €1.45 | €3.74 | 158.617% |
Select Medical Holdings | 6 | 0 | 3 | 0 | €31.40 | €36.41 | 15.944% |
ProQR Therapeutics N.V. | 8 | 1 | 3 | 1 | €1.76 | €3.03 | 72.409% |
Exelixis Inc. | 18 | 0 | 3 | 0 | €19.69 | €26.01 | 32.113% |
Evolus Inc | 9 | 0 | 3 | 0 | €11.90 | €20.43 | 71.702% |
XOMA Corp. | 6 | 0 | 3 | 0 | €22.40 | €68.78 | 207.050% |
Adverum Biotechnologies Inc. | 7 | 0 | 3 | 0 | €1.38 | €5.60 | 305.913% |
Edwards Lifesciences Corp. | 26 | 1 | 3 | 0 | €82.89 | €88.17 | 6.369% |
LivaNova plc | 9 | 0 | 3 | 0 | €56.00 | €66.59 | 18.916% |
Resmed Inc. | 19 | 0 | 3 | 0 | €202.80 | €207.72 | 2.424% |
Icon plc | 18 | 0 | 3 | 0 | €294.40 | €319.67 | 8.583% |
Adaptimmune Therapeutics PLC ADR | 3 | 0 | 3 | 0 | €1.12 | €1.70 | 51.786% |